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Lib RAW'< 
"The credit belongs to the man who is actually 
in the arena, whose face is marred by dust and 
sweat and blood...who knows the great enthusiasms 
the great devotions; who spends himself in a 
worthy cause; who at the best knows in the end 
the triumph of high achievement, and...if he fail 
at least fails while daring greatly, so that his 
place shall never be with those cold and timid 
souls who know neither victory nor defeat." 
J.F. Kennedy 
"To live in the world of creations — to get 
into it and stay in it — to frequent it and 
haunt it — to think intensely and fruitfully — 
to woo combinations and inspirations into being 
by a depth and continuity of attention and medi¬ 
tation — this is the only thing." 
Henry James 
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I. GENERAL INTRODUCTION 
A profound, transient leukopenia has recently 
been described in patients undergoing hemodialysis 
(19,28). The white blood cell count usually begins 
to fall 1-2 minutes after the start of hemodialysis 
and reaches its lowest value (approximately 25% of 
pre-dialysis level) after 2-15 minutes of dialysis. 
By one hour the leukocyte count has returned to nor¬ 
mal. The leukopenia is due to the virtually complete 
removal of neutrophilic granulocytes from the circu¬ 
lating blood. The return to a normal white count is 
associated with the appearance of large numbers of 
immature neutrophils in the circulation. Leukocytosis 
does not follow, nor is there any change in erythro¬ 
cyte or platelet levels. Patients have not had fever, 
chills, rash or other symptoms. If dialysis is halted 
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for five minutes, and then resumed, the leukopenia 
will recur (18). 
This phenomenon was originally observed in 
uremic patients undergoing chronic hemodialysis with 
a twin coil dialyzer, a "single-pass" dialyzing 
apparatus, and a dialyzing fluid of standard compo¬ 
sition. It has since been seen in non-uremic patients 
and in other dialysis units. It occurs with every 
type of dialyzer investigated, i.e., the Kiil Dialyzer, 
Travenol "3/4" coil, and Travenol "ultra-flow 145" coil. 
The neutropenia is not a result of loss of white 
blood cells in the dialysis apparatus. If fresh blood 
is continuously re-circulated around the dialysis 
circuit fn vitno , the white count does not fall. And 
if 1 unit of bank blood is passed through the dialyzing 
apparatus, collected, and transfused into the patient, 
a marked leukopenia is seen after just one minute. 
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This rapidity also suggests that the leukopenia could 
not be accounted for simply by the removal from the 
circulation of the leukocytes which have already passed 
through the dialyzer. 
The fall in white count does not seem to be re¬ 
lated to the introduction of pyrogen. If sterile lac- 
tated Ringer's solution and a sterile dialyzer are used 
in place of the normal dialysate and dialyzer, the 
leukopenia still occurs. If the blood compartment of 
the dialyzer coil is given 5 times the normal rinse 
with sterile saline (10 liters), the leukopenia still 
occurs. And if saline alone is passed through the 
dialyzer and infused into the patient, the white count 
does not fall. 
The leukopenia is not caused by the blood pump 
or tubing used. If blood is allowed to circulate 
through the pump and tubing, bypassing the dialyzer, 
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the patient's white count remains constant. If the 
dialyzer is then introduced into this circuit, the 
white count promptly falls. 
It is clear, then, that the dialyzer is a 
necessary factor in the genesis of the neutropenia. 
However, because dialysis has not been performed with¬ 
out dialysate present, it is not possible to state 
whether the dialyzer membrane, the dialysate, or both 
together are necessary for neutropenia to occur. 
A second necessary factor is the blood. As stated 
above, normal saline or lactated Ringer's solution 
passed through the dialyzer will not cause neutropenia 
when infused into the patient. 
The combination of this "dialyzer factor" plus 
the "blood factor" produces a "leukopenic factor" which 
then requires a "patient factor" to produce leukopenia. 
This is brought out by the observation that the white 
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count of blood re-circulated around the dialyzer cir¬ 
cuit ("blood factor" + "dialyzer factor") does not 
fall (28) . 
The purpose of this study was to elucidate fur¬ 
ther the above factors and their interrelationships. 
The first part of the work was directed at establishing 
the dialyzer membrane as the "dialyzer factor". For 
this purpose and for further experiments, it was neces¬ 
sary to establish an animal model which clearly repro¬ 
duced this leukopenic phenomenon. The dog was chosen 
for this. 
The second phase of this investigation was under¬ 
taken to determine if other plastic surfaces in contact 
with blood during extracorporeal circulation could in¬ 
duce leukopenia. The cardio-pulmonary bypass apparatus 
used during open-heart surgery was studied for this 
purpose. 
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The third part of the work was an investigation 
of the role the lungs play in effecting the leuko¬ 
penia of hemodialysis. 
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II. GENERAL METHODS AND MATERIALS 
A. Dogs 
All dogs used in these experiments were healthy 
mongrels weighing 10-25 kg. They had all been de~ 
wormed and quarantined for 21 days. Sodium pento¬ 
barbital, 30mg./kg., i.v., was used for induction of 
anesthesia; 25mg. supplements were given as the dogs 
became light. 
For simple hemodialysis experiments, anticoagu¬ 
lation was maintained with heparin sodium 200 units/kg., 
i.v., initially, plus 100 units/kg./hour, i.v., there¬ 
after. For dog experiments involving heart-lung bypass 
the initial heparin dose was 500 units/kg., i.v., with 
100 units/kg./hour supplements. 
All operative procedures involving the dogs were 
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carried out under conditions of strict asepsis to 
avoid introducing pyrogens. The basic cannulation 
procedure for hemodialysis involved cutdown and 
isolation of femoral artery and vein, or external 
jugular vein and carotid artery. The vessels were 
cannulated with the plastic catheter from an i.v. 
catheter placement unit. 
B. Hemodialysis 
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Inflow and outflow tubing used was of polyvinyl 
chloride composition. After cutdown of femoral or 
neck vessels, the femoral or carotid artery was used 
for inflow (into the dialyzing apparatus) and the 
femoral or external jugular vein, respectively, for 
outflow. Blood was pumped through the circuit by a 
Sarnes roller pump, usually at a rate of lOOcc./minute. 
The dialyzer used was a Travenol "ultra flow 145" 
and dialysate, when indicated, was of standard composi¬ 
tion (sodium 132 mEq/L; acetate 35 mEq/L; potassium 
2 mEq/L; magnesium 1.5 mEq/L; calcium 2.5 mEq/L; glucose 
200 mg%; and chloride 103 mEq/L). The dialyzer and 
tubing were primed with normal saline. 
C. Laboratory Determinations 
During simple hemodialysis experiments, blood 
9 
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samples were obtained by needle puncture of the inflow 
tubing just distal to the arterial cannulation site. 
Blood was drawn into heparin-containing vacutainer 
tubes. 
For total leukocyte counts duplicate dilutions 
were made with a Fisher automatic diluter. Duplicate 
counts on each dilution were made on a Coulter auto¬ 
matic cell counter. Agreement to within 2.5% was re¬ 
quired on the duplicate counts; the separate dilutions 
also agreed to within 2.5%. 
Duplicate hematocrits were done on each sample to 
provide a basis for correction of hemodilution arti¬ 
facts in white counts. 
Thin smears were made on microscope slides shortly 
after the samples were drawn; they were later stained 
with Wright's stain. Differential white counts were 
performed, counting at least 200 cells on each slide. 
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unless the white count was very low, and then at least 
100 cells were counted. 
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III. DIALYZER FACTOR 
Introduction 
If blood is passed from the patient through the 
dialysis tubing, then through the roller pump, and 
finally returned to the patient, the patient's 
leukocyte count does not fall; however, if the dialyzer 
is suddenly interposed between the pump and the patient, 
a rapid leukopenia follows (28). It is concluded from 
this observation that there is a "dialyzer factor" neces¬ 
sary for this leukopenia to occur. 
The dialyzer consists essentially of a cellophane 
membrane separating blood from dialysate. This experi¬ 
ment was undertaken to determine if the leukopenic 
phenomenon would occur in the absence of dialysate. This 
would then localize the essential "dialyzer factor" to 
12 
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the dialyzer coil (membrane) itself, rather than any 
component of the dialysate. 
It was felt unsafe to perform human hemodialysis 
without dialysate. (Glycerol is used in the prepara¬ 
tion of the dialyzers, and it must be rinsed out be¬ 
fore they are used.) For this reason, and for future 
experiments, dialysis was performed on a dog. This 
was found to reproduce well the leukopenia seen with 
human dialysis. 
Methods 
Thirteen hemodialyses without dialysate were 
performed on 7 dogs with the technique described in 
Part II. However, in all 13 dialyses reported here, 
the dog's blood was used to prime the tubing and coil. 
First a 10-20 minute dialysis had been performed with 
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saline as primer in the tubing and coil. Then 10-20 
minutes were allowed for the dog's white count to 
stabilize, and finally another dialysis was begun, 
this time with the dog's blood from the previous dialy¬ 
sis filling the coil and tubing. The degree of leuko¬ 
penia and the changes in differential leukocyte count 
were identical whether saline or blood was used as 
primer. However, because it takes about 3 minutes 
before blood returns to the dog when saline is used 
as primer, the time of peak leukopenia is delayed. For 
purposes of comparability, only blood-primed hemodialyses 
are included here. 
As a control, 4 hemodialyses were performed on 2 
dogs, with dialysate present. The coils were again 
primed with blood. 
Blood samples were drawn at time 0 (when dog's 
blood first entered the tubing), 1', 2', 3', 5', 7', 
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10', and 15'. Total white counts, differential white 
counts, and hematocrits were performed as described 
in Part II. 
Results 
Table 1 shows the leukocyte response to hemo¬ 
dialysis without dialysate in the dog. Absolute white 
count in cells/mm^ is shown for the time zero white 
count, and all further white counts are expressed as a 
percentage of this initial count. All white counts are 
corrected for hemodilution using the following formula 
WBC 
corrected 
Hematocrit . 
time 0 
Hematocrit 
X WBC 
time x 
time x 
Hemodilution correction varied from 0 to 10% 
There is a precipitous drop in white count during 
the early minutes of dialysis. The lowest white counts 
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occurred in the first 3 minutes in 9 of 13 dialyses. 
The white count dropped to an average 24% (range 12%- 
43%) of the pre-dialysis level. Table 1 also shows that 
the white count gradually returns toward normal soon 
after the peak leukopenia. 
Table 2 shows the differential white counts per¬ 
formed on 7 hemodialyses. The peak leukopenia is assoc¬ 
iated with almost total removal of neutrophils from the 
circulating blood. The absolute number of circulating 
mononuclear cells is slightly decreased or unchanged. 
The four dialyses performed with dialysate present 
yielded very similar results. The peak leukopenic 
white counts were 18%, 20%, 16%, and 28% (mean 20.5%) 
of pre-dialysis levels. The peak leukopenia occurred 
at 2', 3", 7.5', and 1' of dialysis. The 7.5' dialysis 
was performed under conditions of reverse flow, i.e., 
blood was removed from the dog's vein, circulated 
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through the dialysis apparatus, and returned to the 
dog's artery. 
Differential white counts were also similar to 
those of dialyses without dialysate. Again, virtually 
all of the granulocytes were removed from the circula¬ 
tion with little change in the number of circulating 
mononuclear cells. 
Dis cussion 
The leukocyte response of the dog to hemodialysis 
is clearly similar to that seen in humans. The time of 
onset of leukopenia, the degree of leukopenia, the 
gradual return of the white count toward normal, and the 
selective removal of granulocytes from the circulation 
all argue that the mechanism responsible for the dialysis- 
induced leukopenia in man is the same as that in dog. 
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The results of this experiment also demonstrate 
that the leukopenia seen is completely independent of 
the presence of dialysate. The results seen when dialy- 
sate is omitted are similar to those seen when dialysate 
is present; moreover, they are also identical to those 
seen in patients when dialysate is present (28). 
This then localizes the "dialyzer factor" to 
the cellulose membrane. It is this which must interact 
with the blood or some fraction thereof (the "blood 
factor") to provide the stimulus to leukopenia in the 
patient. 
This can be summarized as: 
1) Dialyzer membrane + Blood factor —* Leukopenic factor 
2) Leukopenic factor + Patient factor —* Leukopenia 
The next study was undertaken to determine if 
other apparatus commonly used in clinical medicine, with 
extracorporeal circulation, could produce a "leukopenic 
18 

factor". The polyvinyl chloride bubble oxygenator 
used in open-heart surgery was selected for investiga¬ 
tion. 
19 
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IV. LEUKOCYTE DYNAMICS DURING HEART-LUNG BYPASS 
Introduction 
When it became clear that the essential "dialyzer 
factor" was the cellophane dialysis coil itself, a 
logical question arose: would other plastic materials 
in clinical use, with extensive surface contact with 
blood, also lead to a similar leukopenia? The cardio¬ 
pulmonary bypass apparatus, used during open-heart 
surgery, was chosen for further investigation. The 
apparatus consists of a pump-heater and an oxygenator. 
There are a number of different types of oxygenators, 
but the one most commonly used at this medical center 
is a disposable, plastic bubble oxygenator. 
The question of early leukocyte response to 
heart-lung bypass was a virtually uninvestigated one. 
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The studies of human and dog bypass experiments all 
involved late sampling, with the first sample usually 
obtained at 1 hour, and at the earliest, 15 minutes, 
after the start of bypass. 
This study was in two parts. The first was con¬ 
cerned with delineating the changes in total and 
differential white counts in humans undergoing total 
heart-lung bypass. 
When it became clear that the leukocyte response 
was not of the same character or degree as that seen in 
hemodialysis, one possible explanation was that cardio¬ 
pulmonary bypass was diverting blood away from the 
leukopenia-effector organ — the lung. The second part 
of this work involved shunting part of the cardiac 
output through the pump-oxygenator while still allowing 
the rest of the blood to pass through the heart and lungs. 
This work was carried out in the dog. 
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Methods 
A. Total Heart-Lung Bypass 
Oti/jenxtw 
As shown in the diagram,, both superior and in¬ 
ferior vena cavae are cannulated. Secure ties are 
placed around the cannulae so that no blood is allowed 
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to enter the heart. 
Another cannula, not shown in the diagram, 
diverts coronary sinus flow into the pump-oxygenator so 
that no blood enters the lungs via the pulmonary artery. 
Blood flows by gravity from the cannulae into the oxy¬ 
genator where 0^ is bubbled through the blood column at 
6 liters/minute. The oxygenator is primed with about 
15O0cc. of D5-0.2N NaCl. The flow rate of blood varies 
with the size of the patient, but averages about 4 liters/ 
minute in an adult. After passing through the oxygena¬ 
tor the blood is heated and pumped back to the patient 
via the femoral artery. 
Blood samples were drawn with disposable, plastic 
syringes from a 3-way stopcock in the line just proximal 
to the oxygenator, as shown in the diagram. Samples 
were immediately transferred to heparin-containing vacu- 
tainer tubes and total white counts, differential white 
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counts, and hematocrits were performed as described 
in Part II. 
These studies were performed during 5 randomly 
selected open-heart operations at Yale-New Haven Hos¬ 
pital. Samples were drawn before bypass began, at the 
start of bypass (when blood first entered the apparatus), 
and at 30", 60", 90", 2', 3', 4', 5', 7.5’, 10', 15', 30', 
45', 60', and 901. 
B. Partial Heart-Lunq Bypass ^ , 
i/K yCjer\£'+t>r 

Eight partial heart-lung bypasses were performed 
on 4 dogs by removing a portion of the venous return 
to the heart (via jugular vein cannulization), shunting 
this blood through the pump-oxygenator, and returning 
the blood to the circulation (via femoral artery can¬ 
nula) . A roller pump was used; it was of the same de¬ 
sign as that used for human heart-lung bypass. The 
bubble oxygenator was of the type and manufacture as 
that used in human bypass procedures. The blood was not 
heated. Oxygen was bubbled by tank through the blood 
column in the oxygenator at a rate of 2-3 liters/minute. 
The apparatus was primed with 20cc./kg. of normal saline. 
Blood flow was maintained at 550cc./min. If more than 
one bypass experiment was performed in the same dog, 
15-30 minutes were allowed between experiments so that 
the white count would stabilize. 
Blood samples for hematocrit, total white count, 
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and differential white count were drawn from a 3-way 
stopcock in the line leading from the external jugular 
vein to the bubble oxygenator. 2cc. samples were drawn 
into disposable, plastic syringes and transferred im¬ 
mediately to heparin-containing vacutainer tubes. 
Samples were drawn just as blood entered the oxygena¬ 
tor and at 1', 2', 3', 4.5', 6', 10', 15', and 20'. The 
above-mentioned blood studies were performed using the 
methods described in Part II. 
Results 
A. Total Heart-Lung Bypass 
Graph 1 shows the response of the total white 
count to complete heart-lung bypass in the human. 
White counts are expressed as a percentage of the time 0 
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(as blood first enters the oxygenator) white count. 
Hemodilution artifacts have been eliminated by cor¬ 
recting all white counts in a given experiment to a 
single, arbitrary hematocrit as follows 
Correction Hematocrit 
Hematocrit 
x 
X WBCX = Corrected WBCX 
The hematocrit usually fell to 70%-8Q% of the pre¬ 
bypass level 
The total white count is seen to drop within the 
first 2 minutes to an average of 62.4% (range 41%-78%) 
of pre-bypass levels. It gradually returns toward nor¬ 
mal during the rest of the operation. 
The differential white counts before bypass and 
at the lowest white count are shown in Table 3. There 
is clearly no preferential removal of granulocytes or 
mononuclear cells as the white count falls. 
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B. Partial Heart-Lung Bypass 
Graph 2 and Table 4 depict the changes in total 
leukocyte count during partial bypass. Again, white 
counts are expressed as a percentage of time 0 white 
count; hemodilution artifacts are eliminated as in 
Part A. 
Lowest white counts are seen from 2' to 15® after 
the start of bypass. The mean fall in white count is 
to 75.5% (range 52%-86%) of pre-bypass levels. There 
is not, however, a clear trend toward leukopenia with 
a progressive fall in white count and a later, gradual 
return. In 7 of the 8 experiments, white counts great¬ 
er than pre-bypass white counts occurred in the middle 
of the experiment, independent of any trend. After 
Experiment 26 the bypass tubing was disconnected from 
the dog's cannulae and blood was continuously re- 
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circulated around the bypass apparatus In vZtfLO for 
15 minutes. Samples taken from the tubing during this 
period showed no change in white count. 
This in v-itfio re-circulation served the purpose 
of increasing the surface contact of blood and oxygen¬ 
ator. Thus, immediately after this 15' period was 
finished, the cannulae were reconnected and Experi¬ 
ment 27 was begun. As can be seen in Table 4, the 
results of Experiment 27 were little different from 
the other partial bypasses. 
Discussion 
Although a drop in white count is seen during 
the early minutes of total heart-lung bypass, it is 
different in kind and degree from that seen in hemo¬ 
dialysis. The maximum drop in white count (expressed 
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as a percent of the initial white count) is signifi¬ 
cantly less in the bypass group than in the hemodialysis 
group (p<0.05). Of note also is the fact that the drop 
in white count seen in heart-lung bypass is caused by 
the equal disappearance of granulocytic and mononuclear 
cells, as opposed to the selective neutropenia seen with 
dialyzing apparatus. 
Because it was thought that the absence of the 
lungs in the total heart-lung bypass circuit might be 
masking the leukopenic effect, partial heart-lung bypass 
was performed in the dog. As the dog had been shown in 
the previous experiment (Part III) to demonstrate well 
the leukopenia of dialysis, it was expected that if a 
similar mechanism were operating during bypass, it would 
become apparent under these conditions. 
Graph 2 and Table 4, however, show that the drop 
in white count with partial bypass was, if anything, less 
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marked than that seen with total bypass. And Table 5 
shows that again there is not a preferential removal of 
granulocytes from the circulation. This evidence sug¬ 
gests that the mediator of the dialysis-induced leuko¬ 
penia is not activated under conditions of extracorporeal 
circulation through the bubble-oxygenator. 
Alternatively, one could conclude that the mech¬ 
anism responsible for the leukopenia of dialysis is not 
an all-or-none mechanism; and in the case of heart-lung 
bypass, it is not activated to the same degree as in 
dialysis, perhaps because there is far greater surface 
contact of blood with dialysis membrane than with the 
bubble-oxygenator. 
Although no one had examined the white count dur¬ 
ing the early minutes of heart-lung bypass, there have 
been a number of reports of changes in white counts 
during the later stages (15 minutes - 24 hours). 
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Stephenson and Gollan have observed a marked transient 
leukopenia during total heart-lung bypass in the dog. 
The former observed a fall to 36% of pre-perfusion 
levels under conditions of hypothermia, and to 50% 
under normothermia (38). However, the fall in white 
count was noted only in the post-perfusion (after at 
least 30 minutes of bypass) blood sample. No samples 
during perfusion were reported. He attributed the 
leukopenia to trapping of white cells in the oxygena¬ 
tor. Gollan observed post-perfusion white count de¬ 
creases to 30% of pre-perfusion levels and also attribu¬ 
ted this to adherence of white cells to the extracor¬ 
poreal circuitry (20). Although in both studies the 
pump-oxygenator was primed with a diluting fluid, the 
fall in hematocrit was not of a magnitude equal to the 
leukopenia. It is difficult to conclude that this 
leukopenia, seen at least thirty minutes after the 
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start of bypass, is similar in genesis to that of 
dialysis, especially since the higher flow rates 
through a pump-oxygenator might be expected to accel¬ 
erate the course of the white cell changes. In addi¬ 
tion, Andersen found only a slight in white 
count in 9 dogs undergoing total heart-lung bypass (2). 
As regards partial heart-lung bypass, Melrose, 
Galletti, and Brinsfield et al. have observed transient 
leukopenia in dogs. Melrose observed a fall to 59% of 
pre-perfusion values, but his earliest measurement was 
at 30 minutes after the start of bypass (31). Galletti 
saw an average fall to 34% but made his first measure¬ 
ment at 1 hour (16). And although Brinsfield's first 
determination was at 15 minutes, he observed the lowest 
levels at 30 minutes to 1 hour (9). 
It is questionable whether the leukopenia observed 
in the above investigations bears any relation to the 
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present studies. In both the heart-lung bypasses and 
hemodialyses reported here, the lowest white counts are 
seen much earlier and the white count has rebounded well 
toward normal by the time the above investigators have 
observed their minimal readings. 
There are, then, a number of differences between the 
leukopenia seen with dialyzing apparatus and that seen 
with heart-lung bypass. First, the drop in white count 
is significantly greater during dialysis than during 
bypass. Second, the leukopenia of dialysis is associated 
with a selective neutropenia, whereas during bypass the 
differential white count remains essentially unchanged 
throughout. Third, during dialysis the white count 
continues to fall, in a consistent manner, until a low 
point is reached, after which the leukocyte level 
gradually returns to normal. During bypass, however. 
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there is not such a clear pattern; the white count 
rises and falls in an inconsistent fashion, and it is 
common to see values greater than controls, occurring 
sporadically in the middle of a leukopenic trend. 
There are a number of dissimilarities between hemo¬ 
dialysis and heart-lung bypass which may help explain 
the differences in the leukopenias produced. In human 
cardio-pulmonary bypass, the blood does not circulate 
through the lungs; Part V will show that the lungs are 
of major importance in effecting the leukopenia of 
dialysis. The above partial heart-lung bypass experi¬ 
ments, however, demonstrate that even with the lungs in 
the circulation, the bypass-induced leukopenia is still 
different in kind and degree from the dialysis-induced 
leukopenia. 
There are two other essential differences between 
the partial heart-lung bypass apparatus and the dialysis 
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apparatus as used in the above experiments. First, in 
the bypass procedure venous blood is passed through the 
apparatus and returned to a systemic artery, thereby 
passing through a systemic capillary bed 6e^ote reaching 
the lungs. In hemodialysis, on the other hand, arterial 
blood is passed through the apparatus and returned 
directly to the lungs via a peripheral vein. This does 
not appear to be a significant factor for two reasons. 
Firstly, if dialysis is performed on dogs, using venous 
blood and returning it via a peripheral <xn.t2.J1y, the 
changes in white count are similar to those seen in 
"routine" dialysis-*-. Secondly, similar profound, 
transient leukopenias have been produced by the intra¬ 
arterial injections of agents known to cause a leukopenia 
mediated by pulmonary sequestration. For both of these 
reasons it seems that even if the lungs are the major 
In 4 such dialyses the white count fell to 20%, 25%, 
40% and 45% of the pre-dialysis values. The lowest white 
counts were seen by 3-5 minutes of dialysis. 
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effector-organ, it is not necessary for the "leukopenic 
factor" to pass through the pulmonary capillary bed 
before any other. Therefore, the fact that during 
partial bypass the blood is returned to a systemic 
artery should not be significant. 
Other than the direction of flow, the only other 
essential difference in the two procedures is that in 
heart-lung bypass the blood passes through the poly¬ 
vinyl chloride bubble-oxygenator instead of through the 
cellulose membrane of the dialyzer. This difference, 
then, ("dialyzer factor" vs. "oxygenator factor") would 
seem to account for the dissimilarities seen. 
Again, they differ not only in degree, but in kind 
also. One is a selective neutropenia; the other is non¬ 
specific. One shows a continuous, progressive, repeat- 
able fall in white count; the other shows a more 
inconsistent and erratic leukopenic trend. This evidence 
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perhaps suggests that the two leukopenias are mediated 
by different final pathways. This is supported by the 
observation that a host of other agents (see Part V) 
can induce acute leukopenia, and the pattern of leuko¬ 
penia produced is similar to that seen in dialysis. 
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V. SEQUESTRATION OF LEUKOCYTES IN THE LUNG DURING HEMODIALYSIS 
Introduction 
The lung acts as the major organ in the removal 
of leukocytes under a variety of conditions, such as 
circulation through a Starling heart-lung preparation 
(1); cardiac catheterization (1); respiratory maneuvers 
(8); physiological conditions (8); injection of hydro- 
phile colloids (39), nicotinic acid (8), saccharated 
iron oxide (43), heterospecific blood (8), and bac¬ 
teria (3); and during systemic anaphylaxis (40). Under 
some of these conditions the leukopenia is rapid and 
transient, as is that seen with dialysis. The liver 
and spleen have been shown to play a lesser role in 
effecting leukopenia (8). 
The purpose of this study, then, was to examine 
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directly the role of the lungs in effecting the neutro¬ 
penia of dialysis. 
The basic plan was to measure simultaneously the 
white count of blood entering and blood leaving the 
lung before, during, and after hemodialysis. If the 
lungs were indeed responsible, it was hoped that this 
experiment would demonstrate a dramatic drop in white 
count across the lungs as the peripheral white count 
fell during dialysis. 
Methods 
Six femoral artery to femoral vein hemodialyses 
were performed in 4 dogs by the usual technique (see 
Part II). It was assumed that femoral artery blood 
would be the same as pulmonary blood with respect to 
total and differential white count. It was also 
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assumed that transit time between the pulmonary vein 
and femoral artery was negligible. 
The problem of obtaining pulmonary artery blood 
was more difficult. Because of the unknown, possibly 
irregular effects of the various organs upon the white 
count during hemodialysis, it was necessary to obtain 
samples which were homogeneous, i.e., had passed 
through a mixing chamber, in this case the right ven¬ 
tricle. To this end, right thoracotomy was performed 
and the azygos vein was exposed at its junction with 
the superior vena cava. 
Sit 
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A sterile #10 Bardic plastic catheter was advanced 
through the azygos vein into the superior vena cava, 
through the right atrium, and at least into the right 
ventricle, if not the pulmonary artery. The catheter 
was advanced to a point which had been measured ex¬ 
ternally on the dog's heart to be sufficient to reach 
the right or left pulmonary artery. The superior and 
inferior cavae were carefully palpated to ascertain 
that the catheter had entered the heart. The right 
atrium was carefully palpated to be certain that the 
catheter had not coiled upon itself there. It was then 
assumed that if the proper length catheter had been ad¬ 
vanced, and if the catheter had not been mistakenly 
detained in the cavae or right atrium, then it most 
certainly would be in the right ventricle or pulmonary 
artery. This was confirmed in the two post-mortem 
examinations performed. 
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The pulmonary artery samples were taken after 
first disposing of the lcc. measured dead space of the 
Bardic catheter plus the attached sterile, siliconized 
3-way stopcock. During dialysis, femoral artery samples 
were drawn from the rubber cuff sampling site on the 
inflow tubing (see diagram. Part II, B). However, during 
control periods the blood column was not moving in the 
inflow tubing. For sampling purposes, a sterile, sili¬ 
conized 3-way stopcock was connected to the femoral 
arterial cannula. During control periods samples were 
taken after first disposing of the 0.3cc. measured dead 
space of the arterial cannula plus stopcock. 
The first part of each experiment consisted of a 
20-40 minute control period with all cannulae in place 
and the dog's chest open, but with the dialysis pump 
off. 6-8 samples were drawn simultaneously from pul¬ 
monary artery and vein (= femoral artery) during this 
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control period. 
In the first 4 experiments, dialyses were carried 
on for 15 minutes with simultaneous pulmonary artery 
and vein samples at time 0 (as blood entered dialysis 
apparatus), 1', 2', 3', 4', 5', 7.5', 10', and 15'. 
When 2 experiments were performed on the same dog on 
the same day, a 10 or 15 minute waiting period between 
dialyses was allowed. During this period simultaneous 
pulmonary artery and pulmonary vein samples were drawn 
atO, 2.5', 5', 7', and 10' or 0, 2', 5', 8', 11', and 
15 1 . 
In the last 2 experiments dialyses were carried 
on for 30 minutes with simultaneous pulmonary artery 
and vein samples at 0, (15"), 30", 45", 60", 90", 2', 3', 
4.5', 7', 10', 13 ' , (16'), 19', 22', 25', 28', 30'. As 
soon as dialysis was stopped another series of simultaneous 
samples was taken at 0 (moment dialysis stopped), 1', 
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2 3 ' , 4 ' , 61, 10' , 15', 20 ' , and 25' . 
Hematocrit, total and differential leukocyte 
counts were performed as described in Part II. 
Results 
Results of the total white counts are shown in 
Graphs 3-6. The bars represent change in white count 
across the lung, expressed as a percent change, calcu¬ 
lated with the formula shown on the graphs. A positive 
result indicates release of leukocytes from the lung, 
while a negative result indicates removal by the lung. 
The continuous line graphs indicate pulmonary artery 
and vein leukocyte counts. 
In 29 control paired samples, the mean change in 
white count across the lung was 0.17% (range +16% to 
-12%); the median change was +1.0%. 
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During each of the 6 dialyses there is a rapid 
drop in white count, always beginning by 1 minute, at 
the latest. In each case, as the white count is falling 
there is a sharp drop across the lungs. The maximum 
drop across the lungs averages 54.5% (range 48%-67%). 
The marked drop in white count across the pulmonary 
vascular bed is consistent within each experiment and 
from one experiment to the next. Of 40 paired samples 
taken during the early minutes (as the white count was 
falling) in these 6 dialyses, there is only one read¬ 
ing that is inconsistent with these findings. This is 
seen at 7.5' of the first dialysis on Graph 3. 
There is no apparent trend toward sequestration or 
release of leukocytes as the white count returns toward 
normal, or after dialysis is stopped.. 
Table 6 illustrates the change in differential white 
count across the lung at the peak of leukopenia. Three 
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typical control readings are also included. It is clear 
that the drop in white count is accounted for by the 
selective sequestration of granulocytes. During control 
periods there is essentially no change in differential 
counts across the lungs. 
Dis cussion 
In all 6 dialyses the early fall in white count 
is attended by a marked sequestration of neutrophils 
in the lungs. When compared with the change in white 
count across the lung in control periods, this 
pulmonary sequestration while the white count falls 
is statistically significant at the 0.001 level. The 
timing of the drop across the lungs, the specific 
sequestration of in the lungs, and the mag¬ 
nitude of the drop in white count across the lungs, all 
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suggest strongly that the pulmonary vascular bed plays a 
major role in effecting the leukopenia. No conclusions 
can be drawn from the data as to whether this sequestra¬ 
tion of leukocytes occurs only in the lungs. 
Close inspection of the graphs at the times when 
the white count is rising just after the peak leukopenia 
shows that white cells are not being released from, the 
lungs in large numbers. This, plus the increasing 
numbers of immature granulocytes, suggests that the in¬ 
crease in peripheral white count is due to released 
leukocytes from extra-pulmonary sites, probably primarily 
from the marrow. This is in agreement with the findings 
of Athens et al. (4), Webb (40), and Weisberger et al. 
(41,42) 
Hemodialysis is not unique in inducing an abrupt, 
transitory leukopenia. Many other agents have been re¬ 
ported to cause this type of leukopenia, and these agents 
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may be grouped accordingly as: 
Pyrogen-associated References 
bacteria 3,10,11,15,22,27,33,34,37 
non-specific bacterial products 27 
pyrogen 6,44 
endotoxin 4 
Leukocyte-associated. 
leukocytes 41,42 
products of disintegrated 
leukocytes 
41 
inflammatory exudates 32 
"leukopenic factor" isolated 
from inflammatory exudates 
32 
leukocytes from an empyema 36 
Anaphylaxis-associated 
horse serum 6,14,40 
bacteria 3 
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Colloid-associated References 
fibrinogen 39 
nucleic acid 39 
starch 39 
gum arabic 39 
tragacanth 39 
salep mucilage 39 
dextran 14,30 
acacia 14,30 
methyl cellulose 24 
hepatic glycogen 14 
chemically-pure glycogen 26 
quartz particles 13 
saccarated iron oxide 8,43 
gelatin 8,39 
plasmoid. 8 
globulin 39 
A discussion of the leukopenias associated with these 
4 groups of agents may shed some light on the mechanism 
responsible for the leukopenia of dialysis. 
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The first report in the English literature of 
bacteria-related leukopenia appeared in 1892 (27). 
Kanthack injected filtered or sterilized cultures of 
Vibrio metchnikovi, Pseudomonas aeruginosa, and yeasts 
into the ear vein of a rabbit. He saw a marked (unspec¬ 
ified) leukopenia, associated with fever, and followed 
by leukocytosis. The leukopenia was seen 1 hour after 
injection, but this was his first sampling. The se¬ 
quence of leukopenia and leukocytosis following intra¬ 
venous or intraperitoneal injection of bacterial pro¬ 
ducts in man and animals has been demonstrated by many 
workers (3,4,10,11,15,22,27,33,34,37,44). The typical 
pattern is a drop in white count to 15%-35% of the nor¬ 
mal level, usually by the time the first sample has 
been drawn. This occurs as early as 1 minute after 
bacterial challenge, but is more common at 1 hour. The 
leukopenia persists for about 2 hours, followed by a 
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leukocytosis, reaching a peak at 6 - 12 hours; the white 
count gradually returns to normal by 24 hours. 
Andrewes showed that enteric gram negative bacteria 
produce the most dramatic leukopenia, with greater than 
90% of the neutrophils removed from the circulation at 
1 minute (3). The response to killed bacteria is the 
same as that to living bacteria. Andrewes also showed 
that the pulmonary capillaries are responsible for most 
of the sequestration. He sacrificed rabbits 15 minutes 
after injection of bacteria, and immediately fixed their 
lungs, liver, spleen, kidneys and marrow in formalin. 
Compared to control animals there was a great increase 
in the concentration of leukocytes in the lungs, but 
essentially no change in the other organs. He also 
states that "calculation shows that the observed increase 
in the lung tissue is sufficient to account for the 
observed decrease in the peripheral circulation." He 
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suggests that there is something specific about the 
pulmonary vascular bed, but it must be remembered that 
the bacteria were introduced into the venous circulation 
and thus passed through the pulmonary capillaries before 
any others. Also, the pulmonary capillary bed is far 
the largest of any organ in the body. 
An earlier demonstration of the importance of the 
lungs in this regard had been provided by Ewing, who re¬ 
trieved liver, lungs, heart, kidney, spleen, and femur 
at varying time intervals after ear vein injection 
(rabbit) of pseudomonas aeruginosa (15). He found that 
both liver and lungs had a 2-3 - fold increase in 
leukocyte concentration when the leukopenia was most 
marked as compared to controls. Bruce also concluded 
from histological inspection that during peak leukopenia 
the leukocytes accumulate in the capillaries of the lungs 
(10) . 
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More recently, Athens et al. have found a mild 
leukopenia in human volunteers after the intravenous 
injection of a highly purified, protein-free, lipo- 
polysaccharide endotoxin from Salmonella abortus equi 
(4). They saw a drop to 67% of control values, but 
their first sample was taken 1.5 hours after challenge. 
As regards the leukopenia of dialysis, it seems 
untenable to hold that a pyrogen is involved, since 
the patients have never demonstrated fever or other 
symptoms. But on the other hand the leukopenias 
associated with pyrogen and dialysis have much in common. 
The degree of leukopenia and the time course are similar; 
in both situations the lungs play the major role in 
removing the leukocytes; and in both there is a selective 
neutropenia. 
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Leukocyte-associated leukopenias comprise the second 
major group to be discussed. Although this group is 
presented separately from the pyrogen-associated leuko¬ 
penias, they may have a similar pathogenesis. Leukocytes 
themselves have been shown to be a source of endogenous 
pyrogen (5). 
Weisberger et al. obtained a concentrated leukocyte 
solution by injecting saline into a rabbit's peritoneum 
and later withdrawing the peritoneal fluid (41). They 
subjected the white cells obtained to supersonic 
vibration and centrifugation, and then injected the 
particle-free supernatant into the same and other rabbits 
(intravenously). In all cases a prompt neutropenia 
ensued, beginning 1-5 minutes after injection, reaching 
a peak leukopenic white count 20-30% of control levels. 
The leukopenia lasted 30 minutes to 5 hours, and about 
half the animals then had a leukocytosis beginning 2-4 
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hours after challenge. Injection of the intact leuko¬ 
cytes produced the same results. 
In later studies Weisberger et al. injected simi¬ 
larly obtained. P labeled white cells into rabbits and 
32 
sacrificed them 30 minutes later (42). He then took 
radioactive counts of lungs, liver, spleen, kidneys, 
lymph nodes, thymus, skeletal muscle, femur, skull bones, 
and brain. The lungs contained by far the greatest part 
of the radioactivity, both as a fraction of the total 
radioactivity administered and as a percent of the total 
activity injected per gram of tissue. Of particular im¬ 
portance was the fact that he obtained the same results 
when the white cells were injected intravenously, as when 
they were injected intra-arterially. These findings were 
also corroborated by histologic examination which showed 
marked engorgement of lung capillaries with leukocytes. 
This last study demonstrates that it is not the intravenous 
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route of administration that the responsible for the 
predominant role the lungs play in bringing about the 
leukopenia. 
Under the conditions of their experiments whole 
blood did not produce the leukopenia; moreover, the 
leukocytes they obtained from the rabbit peritoneum 
exhibited normal phagocytic activity, normal ameboid 
activity, and took up vital stains. In search for a 
mediator of this leukopenia they showed that in¬ 
travenous histamine could not duplicate their results, 
nor could intravenous anti-histamines prevent the 
leukopenia seen with injection of leukocytes. 
There are striking similarities between this work 
and the leukopenia of dialysis. In both situations 
there is a "blood factor" which appears normal in vitno, 
but which on re-introduction to the host promptly effects 
a sequestration of neutrophils in the lungs. In addition, 
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in Weisberger's work, the bn vitJio combination of the 
white cell solution and whole blood produces no change 
in the in vitno white count. This is again similar to 
what is seen with dialysis. 
Perhaps also related to the active agent in white 
cells is the leukopenic factor isolated from inflammatory 
exudates by Menkin (32) . The whole exudate, a 15 leuko¬ 
penic factor" extracted from the euglobulin fraction of 
the exudate, and a pyrogen Opyrexin") frequently found 
in association with the "leukopenic factor", all caused, 
a drop in white count to about 1/3 of control levels 
(first sample at 1 hour after intravenous challenge). 
Careful postmortem examination revealed large numbers of 
white cells in the alveolar walls of the lungs, the sinus¬ 
oids of the liver, and the pulp of the spleen. 
There is a striking similarity between the above 
leukocyte-associated leukopenia and that seen with 
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hemodialysis. The degree of leukopenia is almost 
identical; the time course, especially as regards the 
rapidity of the drop in white count, is similar in both; 
the lungs play a major role in effecting the leukopenia 
in both; and in both cases there is a selective neutro¬ 
penia. These similarities strongly suggest a final 
common pathway. 
The third major group of agents causing abrupt 
leukopenia is related to anaphylaxis. Andrewes first 
presented suggestive evidence of this in 1910 while 
investigating the effects upon the white count of 
injecting bacteria into rabbits (3). He found that 
bacteria caused a profound leukopenia upon first 
injection; but if he challenged the same animal with 
the same strain of bacteria 2-3 weeks after the first 
challenge, the drop in while count was to 1/10 the 
previous minimum level. In addition, the rabbits showed 
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signs of anaphylaxis; indeed, the degree of shock 
correlated well with the degree of leukopenia. 
A more definitive study was done by Webb in 1924 
(40). He sensitized dogs with 3 subcutaneous injections 
of horse serum and challenged them 20 days later with 
intravenous injection of horse serum. The white count 
fell to an average of 25% of control levels, beginning 
as early as 36 seconds after challenge. Differential 
white counts showed a drop in polymorphonuclear leuko¬ 
cytes from 65% at control to 2% at peak leukopenia. 
The white count had returned to normal by 2-3 hours. 
This again is very similar to the pattern seen in hemo¬ 
dialysis . 
He checked liver sinusoidal, portal vein, mesen¬ 
teric vessel, intestinal capillary, splenic capillary 
and marrow capillary blood white counts and found them 
to be the same as circulating blood. He obtained 
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capillary samples by slashing the organs at surgery 
and doing white counts on the blood dripping from them. 
When he so examined the lungs he found the lowest levels 
of leukocytes anywhere; he concluded that the leukocytes 
were being held tenaciously to the pulmonary vascular 
bed. He examined the lungs histologically and found 
leukocytes unquestionably crowd the pulmonary capillaries 
in very impressive numbers" during leukopenia. To 
further corroborate the dynamic importance of this he 
took simultaneous right and left ventricular blood samples 
before and during challenge with antigen. Results showed 
similar white counts during control periods; but after 
antigen challenge, he demonstrated left ventricular 
white count slightly less than 50% of right ventricle 
count as the peripheral white count was falling. By 6 
minutes the 2 counts were equal and continued up slowly 
together. These results are again remarkably similar to 
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those shown in this present study. 
To further substantiate his belief that this 
reaction was specific to the lungs, he isolated a seg¬ 
ment of small intestine, cutting off proximal and distal 
vascular anastamoses. He cannulated the vein and artery 
serving this segment, injected antigen into the artery 
(the rabbit had been sensitized), and measured simul¬ 
taneous arterial and venous white counts. He found no 
change in white count across the intestinal segment, con¬ 
cluding that sequestration occurred only in the lungs. 
However, the mediators of the anaphylactic reaction may 
not have been present in the intestinal loop. When 
antigen is injected systemically the active mediators of 
leukocyte sequestration may be released into the general 
circulation and the sequestration may be a generalized 
process. 
Essex presented evidence to suggest this. He 
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imolanted a transparent chamber in a rabbit's ear in 
order to observe microscopically the dynamic situation 
in the vasculature under various conditions (14). He 
sensitized a rabbit with horse serum, and on challenge 
saw greatly increased stickiness and adhesiveness of 
leukocytes, which adhered to the endothelium and to 
each other, sometimes blocking the vessel. 
Thus the evidence is that quantitatively the lungs 
remove the bulk of the leukocytes from the circulation 
during anaphylaxis-induced, leukopenia. It is probably, 
however, a generalized reaction. 
In comparing these results with what is seen with 
dialysis there is again a striking similarity in the 
time course,the degree of leukopenia, the importance 
of the lungs, and the specific disappearance of nuetro- 
phils. As in the cases of pyrogen-associated and 
bacteria-associated. leukopenias, these similarities 
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strongly suggest a final common pathway. Anaphylaxis 
is also a complex, incompletely understood phenomenon, 
and the absence of signs of anaphylaxis in dialysis 
patients does not mean that dialysis and anaphylaxis 
do not share a final pathway or for that matter, an 
even more basic mediator. 
The fourth group to be discussed is the group of 
hydrophile colloids. They are all highly viscous, and 
reduce the suspension stability of the blood (increase 
the erythrocyte sedimentation rate). 
The findings of White, Bierman, Kelly, and Byron, 
Jr. are typical (43). They injected a colloidal 
suspension of saccharated iron oxide intravenously into 
13 patients. Simultaneous samples from a peripheral 
artery and either the inferior vena cava, right ven¬ 
tricle, or pulmonary conus showed onset of leukopenia 
30 seconds to 5 minutes after injection with the nadir 
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at 3-20 minutes. The leukopenia was manifest first on 
the arterial side of the lungs (oxygenated blood), followed 
in 30-90 seconds by the venous side. The white count 
usually fell to 15%-35% of control levels, and when 
differentials were done, the fall in white count was seen 
to be mostly from a drop in number of circulating granu¬ 
locytes. A leukocytosis usually followed but did not 
reach a peak often until 24-48 hours, requiring a week 
to return to normal. 
Essex, using the transparent chamber in the rab¬ 
bit ear (14), and Veglens, studying guinea-pig, rabbit, 
and cat mesentary under a microscope (39), both found 
that with injection of a variety of colloids there 
follows a tenacious adherence to endothelium by leuko¬ 
cytes ("margination"). They both conclude that this is 
a generalized response and not peculiar to the pulmonary 
vascular bed. 
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Of particular interest is the observation by 
Hueper that methyl cellulose causes the characteristic 
leukopenia (24). This is simply the methyl ester of 
cellulose, the membrane ("dialyzer factor") of the 
dialysis coil. 
Hueper (24,25,26), Essex (14), Bierman (8), and 
Veglens (39) all concluded that it is the colloidal 
nature of these agents which is responsible for the 
leukopenia seen. Hueper simply states that the abnor¬ 
mal colloidal status of the blood and especially the 
increased viscosity of the blood and particularly the 
plasma are responsible (24). Veglens showed that certain 
agents which have some characteristics similar to the 
colloids, but which do not influence the suspension 
stability of the blood and which do not have a high 
viscosity, such as egg albumin, dextrose, and saccha¬ 
rose, produce no change in white count (39). 
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As in the two previous major groups there is an 
impressive similarity between the time course and 
nature of this leukopenia and that seen with dialysis. 
In addition, the finding that an ester of the cellulose 
membrane (the "dialyzer factor") itself can reproduce 
the entire leukopenic phenomenon when introduced into 
the circulation strongly suggests a similar etiology. 
The observation that saline passed through the dialysis 
coil will not cause leukopenia might be explained by 
the necessity of some agent in the blood to draw the 
cellulose into solution or suspension. 
There is, then, no clear evidence to implicate 
specifically the pyrogen-associated, the anaphylaxis- 
associated, or the colloid-associated mechanisms as 
responsible for the leukopenia of dialysis. On the 
other hand, the characteristics of all the leukopenias 
seen under the variety of conditions discussed above 
67 

are remarkably consistent: 
1) The white count falls to 20%-30% of control 
values. 
2) The fall in white count occurs by 30 seconds 
to 5 minutes at the latest, if early samples are taken. 
3) The fall in count is due to specific removal of 
neutrophils from the circulation. 
4) The lungs always play the major role in the 
sequestration of the leukocytes. 
The stiking similarity of these leukopenias, induced 
under such a variety of circumstances, strongly sug¬ 
gests that all of them are mediated by a final common 
pathway, perhaps involving increased adhesiveness of 
leukocytes (neutrophilic granulocytes in particular) 
to endothelium and to one another. The bulk of the 
evidence also shows that although the lungs are 
quantitatively paramount in effecting the leukopenia. 
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both in dialysis and the other models, the 
tion of leukocytes under these stimuli is 
reaction. 
sequestra- 
. systemic 
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VI. SUMMARY AMD CONCLUSIONS 
1. Details are presented of a profound, transient 
leukopenia seen in humans undergoing hemodialysis. 
2. 13 dialyses were performed on 7 dogs with similar 
techniques to those used in humans except that 
dialysate was not used. It was shown that the dog 
is an excellent animal model for the dialysis-in¬ 
duced leukopenia. It was also shown that the 
dialysate is not necessary to produce the leuko¬ 
penia. This further localized the "dialyzer fac¬ 
tor" to the membrane. 
3. Total and differential white counts were performed 
during 5 open-heart operations utilizing a poly¬ 
vinyl chloride bubble-oxygenator for cardio-pul- 
monary bypass. A drop in white count was seen 
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during the early minutes of bypass, but this drop 
was significantly less than that seen with dialysis. 
In addition, there was no significant change in 
differential white count during bypass. The same 
results were seen when partial bypass was performed 
on dogs, allowing a part of the venous return to 
the heart to pass through the bubble-oxygenator, 
while still allowing blood to circulate through the 
lungs. It is concluded that the leukopenia occurring 
during heart-lung bypass may well be mediated by a 
mechanism different from any discussed in this paper. 
4. Simultaneous pulmonary artery and pulmonary vein 
(= systemic artery) samples were obtained during 6 
dialyses on 4 dogs. It was clearly demonstrated 
that while the white count is falling there is a 
sequestration of white cells in the lungs. Various 
other leukopenias are described, and the relation- 
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ship of these to the leukopenia of dialysis are 
discussed. Evidence presented suggests that 
all leukopenias discussed, there is a shared 
common pathway. 
in 
final 
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APPENDIX 
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Table 1 
Leukocyte Response To Hemodialysis In The Dog 
Exp. No.- #1 #2 #3 #4 #5 #6 #7 
00
 #9 #10 #11 #12 #13 
Time 1 
6800 9100 8200 9800 13700 7800 5800 8500 14800 8900 10300 8500 5900 
Time 0 
WBC/mm^ 
0 100 100 100 100 100 100 100 100 100 100 100 100 100 
1' 85 m 26 21 72 43 71 54 129 75 38 
2 ' 18 24 37 23 31 
3 ' * 34 ■ ■ 24 27 50 34 26 13 47 I** ill 
5' 57 60 32 29 29 29 56 34 
4' : 12 4' :26 
21 35 5 1 :13 5 ' : 36 
7 ' 60 55 27 46 59 20 57 41 52 12 49 31 59 
10' 92 56 42 56 62 26 69 58 51 18 57 38 66 
15' 66 70 61 22 50 
Leukocytes, expressed as percentage of pre-dialysis white count 
shaded values indicate peak of leukopenia 

Table 2 
Differential White Counts Before 
Dialysis And At The Peak Of Leukopenia 
PRE-DIALYSIS PEAK LEUKOPENIA 
Differentials 
Absolute 
counts; 
cells,/^ 7 mm3 Differentials 
Absolute 
counts; 
cclls/*3 
Exp.' 
No. 
S N 
i 
M ■ S+N — 
M 
S N M S+N 
M 
1 11 56 30 
4550 
2040 5 4 
.
—
 
00
 224 
1930 
2 
!. .. S 
16 54 26 6370 
2360 
4 6 88 200 
1760 
9 44 41 12 12600 
1780 15 26 59 
910 
1330 
O
 
i—1
 
— 
42 38 20 7130 
1780 0 4 96 
43 
1025 ]- "T 
1 11 j 
12 
1 . 
30 49 21 8040 
2160 22 26 52 
1270 
1390 
49 
i _) 
29 21 6630 
1790 2 8 90 
136 
1210 
13 
1_ i 
t 
21 44 
— 
29 3840 
1710 6 6 82 
147 
1450 
S - segmented neutrophilic granulocytes 
H — non-segmented neutrophilic granulocytes 
M = mononuclear cells = lymphocytes + monocytes 

Table 3 
Differential White Counts 
Total Heart-Lung Bypass And At The 
Before 
Peak Of Leukopenia 
PRE-BYPASS PEAK LEUKOPENIA 
Differentials 
J 
Absolute 
counts; 
cells/ o 
mm-3 
Differentials 
Absolute 
counts; 
cells/ -5 7 mm-3 
! ! 
Exp. 
No. S N M 
S+N 
M S N M. 
S+N 
M 
18 52 24 22 15350 
4450 
1 
45 28 26 6940 
2465 
19 69 17 12 16200 
2260 
61 24 15 10800 
1900 
20 37 
— 
42 20 8220 
2080 
21 40 33 26 6720 
2390 
41 46 13 3220 
482 
23 41 45 14 13500 
2200 
r 
38 40 
— 
22 9450 
2660 
-1 
S= segmented neutrophilic granulocytes 
N= non-segmented neutrophilic granulocytes 
M= mononuclear cells = lymphocytes + monocytes 

Table 4 
Leukocytes Responses 
To Partial Heart-Lung Bypass In The Dog 
Exp. No r* 
Time ^ 
#25 #26 #27 
r 
#28 #29 #30 #31 #32 
Time 0 
WBC/mm^ 17100 16000 16600 11600 9000 3900 8600 6800 
0 100 100 100 100 100 100 100 100 
1' 
-__  
106 89 86 96 87 98 94 72 
2 ' 100 
_ 
■ 83 93 81 98 103 87 
Minutes 
of 
Bypass 
3 ’ 86 88 92 107 106 108 83 94 
4h' 
' 
85 
' ' y%y ' yky'yk'y //vs y/sy 
96 94 87 88 69 81 97 
6 ' 107 95 92 92 81 75 78 102 
10 ' 92 107 100 83 86 94 
1 
75 
'k/ £ <&&&£. 
83 
15 ' 97 110 73 124 126 83 52 
Kyy/v/yV/V// 
20 ' 63 
25 ' 106 56 
30 ' 77 
Leucocytes, expressed as percentage of pre-bypass 
white count. 
—s shaded values indicate peak of leukopenia 

Of Leukopenia 
Table 5_ 
Differential White Counts Before 
Partial Heart-Lung Bypass And At The Peak 
PRE-BYPASS PEAK LEUKOPENIA 
Differentials 
I 
Absolute 
counts; 
cells/2^3 
Differentials 
Absolute 
counts; 
cells/mm3 
Exp. 
No. 
| 
S N M S+N 
M 
S N M S+N 
M 
25 33 35 34 11600 
5810 
55 23 21 10700 
2840 
26 
[1 
46 36 18 13000 
2880 
41 39 19 11800 
2800 
27 36 51 13 14400 17 62 21 10300 — 
2160 2750 1-- 
31 53 19 19 4900 46 18 30 2300 
1280 1070 
S = segmented neutrophilic granulocytes 
N = non-segmented neutrophilic granulocytes 
M = mononuclear cells = lymphocytes + monocytes 

Table 6 
Differential White Counts From 
Simultaneous Pulmonary Artery And Pulmonary Vein Blood 
At The Peak Of Leukopenia And During Control Period 
PEAK 
CONTROL 
1 
PULMONARY 
ARTERY 
PULMONARY 
VEIN 
’i Absolute Absolute 
Differentials counts; Differentials counts; 
cells/ mir[3 
, 
cells/mm3 
Exp. S N M S+N S N ; M S+N 
No. M M 
34 17 47 30 3690 15 26 58 900 
1260 1270 
~ 
35 47 
• 
27 25 1700 0 4 96 44 
576 
1. 
1060 
36 32 47 20 4100 22 26 52 
| 
1345 
:: 1040 1460 
37 23 20 53 1460 2 8 90 150 
1800 1350 I 
38 28 23 43 1580 6 6 82 240 
1330 1390 
Control 38 49 13 7140 42 38 20 7120 
Exp. 35 1065 1780 
Control 48 32 19 9050 49 29 21 6650 
Exp. 37 2145 1780 
Control 34 31 26 3770 21 44 29 3830 
Exp. 38 1510 1 1 1710 
S = segmented, neutrophilic granulocytes 
N = non-segmented neutrophilic granulocytes 
M = mononuclear cells = lymphocytes + monocytes 

GRAPH 1 
MINUTES OF BYPASS 

All Values Corrected To 
Au Bmitrbrv HemflTocRiT 
MINUTES OF BYPA SS 

31 
CHANGE IN WHITE BLOOD CELL COUNTS 
FRon PULFiONHRy artery to pmncwARy vein 
IN DOGS UNDERGOING HEMODIALYSIS 
GRAPH 3 
lines Represent 
TOTAL 
WHITE count/ 3 It 
/pin 
BARS REPRESENT 
CHANGE IN 
WHITE COUNT 
ACROSS THE LUNGS 
EXPRESSED AS: 
Pulmonary Vein IUBC - fWioxfley Artery W8C 
Puldonaey Asterv UJBC 
Au. Lintte Counts Corrected To 
HenRTOcRiT of 35 % 
_PuLnoNRey Vein 
__Pultonue* fleteev 
o 
START 
HE MO OIA LYSIS 
15 
STOP 
HEMODIALYSIS 
15 
START 
HE PIODIA LYSIS 
-CONTROL PERIOD- 
MINUTES 

3HRS REPRESENT 
change in 
WHITE COUNT 
ACROSS THE LUN6S 
EXPRESSED AS’. 
+30/ 
PutmownRy Vein W8C - Puhonrry Artery UJBC 
Piumon/ARy flRTERX WBC 
~X 100 
■w0 
-10% 
LINES REPRESENT 
TOTAL 
white count/, /tm 
WBC* |0 
flu. White Counts CoMecTED 1o 
HEnHToCErr or 34% 
PusnowflEY Ve.nY 
Puimo*flSY AltTEBY 
CHANGE IN UJHITE 0LO 
FROn PULPIONARy flRTERy TO 
IN DOGS UNDERGOING HE 
0 D CELL COUNTS 
PULPONARy VEIN 
nODIALVSIS 
3S +0 
MINUTES 
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